Vitrectomy combined with periocular/intravitreal injection of steroids for rhegmatogenous retinal detachment associated with choroidal detachment

Retina

Volumn 34, Issue 1, 2014, Pages 136-141

  Wei, Yong ^a,c   Wang, Ningli ^b   Chen, Fenghua ^b   Wang, Huaizhou ^b   Bi, Chuncao ^a   Zu, Zhongqiao ^a   Yang, Xingguang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c XI AN NO 4 HOSPITAL   (China)

Author keywords

Choroidal detachment; Intravitreal injection; Pars plana vitrectomy; Periocular injection; Rhegmatogenous retinal detachment

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; SILICONE OIL; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CHOROID DETACHMENT; CILIARY DISK; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; REOPERATION; RETINA DETACHMENT; SYSTEMIC THERAPY; TREATMENT OUTCOME; VITRECTOMY;

ADULT; AGED; CHOROID DISEASES; COMBINED MODALITY THERAPY; ENDOTAMPONADE; FEMALE; FLUOROCARBONS; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; SILICONE OILS; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 84891891168     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182923463     Document Type: Article

References (31)

1. Gottlieb F. Combined choroidal and retinal detachment. Arch Ophthalmol 1972;88:481-486.
2. Seelenfreund MH, Kraushar MF, Schepens CL, et al. Choroidal detachment associated with primary retinal detachment. Arch Ophthalmol 1974;91:254-258.
3. Sharma T, Challa JK, Ravishankar KV, et al. Scleral buckling for retinal detachment. Predictors for anatomic failure. Retina 1994;14:338-343.
4. Yang CM. Pars plana vitrectomy in the treatment of combined rhegmatogenous retinal detachment and choroidal detachment in aphakic or pseudophakic patients. Ophthalmic Surg Lasers 1997;28:288-293.
5. Sharma T, Gopal L, Badrinath SS. Primary vitrectomy for rhegmatogenous retinal detachment associated with choroidal detachment. Ophthalmology 1998;105:2282-2285.
6. Sharma T, Gopal L, Reddy RK, et al. Primary vitrectomy for combined rhegmatogenous retinal detachment and choroidal detachment with or without oral corticosteroids: a pilot study. Retina 2005;25:152-157.
7. Ghoraba HH. Primary vitrectomy for the management of rhegmatogenous retinal detachment associated with choroidal detachment. Graefes Arch Clin Exp Ophthalmol 2001;239: 733-736.
8. Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995;120:55-64.
9. Okada AA, Wakabayashi T, Morimura Y, et al. Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol 2003;87:968-971.
10. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 2000;84:1064-1067.
11. Watanabe K, Ideta H, Nakatake J, et al. Statistical study of aqueous flare in rhegmatogenous retinal detachment [in Japanese]. Nihon Ganka Gakkai Zasshi 1994;98:653-657.
12. Campochiaro PA, Jerdan JA, Glaser BM. Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol 1984;102:1830-1833.
13. Cook C, Macdonald RK. Effect of cortisone on the permeability of the blood-aqueous barrier to fluorescein. Br J Ophthalmol 1951;35:730-740.
14. Rubsamen PE, Cousins SW. Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy. Retina 1997;17:44-50.
15. Ando N, Sen HA, Berkowitz BA, et al. Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy. Arch Ophthalmol 1994;112:117-122.
16. Brockhurst RJ, Schepens CL, Okamura ID, et al. Scleral buckling procedures. 8. Preoperative complications. Arch Ophthalmol 1965;74:792-798.
17. Graham RO, Peyman GA. Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis. Arch Ophthalmol 1974;92:149-154.
18. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980;90:810-816.
19. Chandler DB, Rozakis G, de Juan E Jr, et al. The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy. Am J Ophthalmol 1985;99:686-690.
20. Schindler RH, Chandler D, Thresher R, et al. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 1982; 93:415-417.
21. Scholes GN, O'Brien WJ, Abrams GW, et al. Clearance of triamcinolone from vitreous. Arch Ophthalmol 1985;103: 1567-1569.
22. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110:681-686.
23. Yang CS, Khawly JA, Hainsworth DP, et al. An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy. Arch Ophthalmol 1998;116:69-77.
24. Ryan SJ. The pathophysiology of proliferative vitreoretinopathy in its management. Am J Ophthalmol 1985;100:188-193.
25. McCuen BW, Landers MB, Machemer R. The use of silicone oil following failed vitrectomy for retinal detachment with advanced proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1986;224:38-39.
26. Kivilcim M, Peyman GA, El-Dessouky ES, et al. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers 2000;31:474-478.
27. Ahmadieh H, Feghhi M, Tabatabaei H, et al. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ophthalmology 2008;115:1938-1943.
28. Jonas JB. Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil. Br J Ophthalmol 2002;86: 1450-1451.
29. Degenring RF, Jonas JB. Rinsing of the cannula prior to intravitreal injection. Arch Ophthalmol 2004;122:1571-1572.
30. Smithen LM, Ober MD, Maranan L, et al. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 2004;138:740-743.
31. Munir WM, Pulido JS, Sharma MC, et al. Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy. Can J Ophthalmol 2005; 40:598-604.